Navigation Links
Cardica Announces Fiscal 2008 Second Quarter Financial Results and Business Progress
Date:1/24/2008

REDWOOD CITY, Calif., Jan. 24 /PRNewswire-FirstCall/ -- Cardica, Inc. (Nasdaq: CRDC) today reported financial results and corporate progress for its fiscal 2008 second quarter and six months ended December 31, 2007.

"We continue to make excellent commercial progress, with over 1,000 C-Port systems shipped in the past quarter for the first time, an expanding product line designed to enable minimally-invasive cardiac surgery and substantial advancement for our development-stage products," said Bernard A. Hausen, M.D., Ph.D., president and chief executive officer of Cardica, Inc. "Moving forward, we will build on our momentum with a significant presence at the Annual Meeting of the Society for Thoracic Surgeons (STS) next week where we will feature our reloadable, cartridge-based C-Port(R) xA X-CHANGE(TM) system, host a joint robotic seminar with Intuitive Surgical, participate in a physician education event featuring our anastomosis products and train surgeons on the use of our devices at STS University."

Recent Highlights and Accomplishments

Commercial Progress

-- Trained a total of 232 surgeons on C-Port(R) Distal Anastomosis Systems

since product introduction;

-- Increased cumulative worldwide shipments of C-Port systems to over

3,600 units, with more than 1,000 units sold in the fiscal 2008 second

quarter;

-- Increased cumulative worldwide shipments of PAS-Port(R) Proximal

Anastomosis Systems to over 7,300 units, with more than 560 units sold

in the fiscal 2008 second quarter, of which the vast majority of units

were deployed in Japan;

-- Reported data at the 2007 American Heart Association Scientific

Sessions demonstratin
'/>"/>

SOURCE Cardica, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Cardica and Intuitive Surgical to Host Educational Symposium on Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair
2. Cardica and Cook Sign Agreement to Expand Cook Vascular Closure Device Product Family
3. Cardica Receives European CE Mark for C-Port Flex A System for Use in Coronary Artery Bypass Surgery
4. Cardicas C-Port(R) Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed-Chest Heart Bypass Surgeries
5. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2007 Financial Results
6. Gerson Lehrman Group Announces Partnership With BIO to Provide Scientific Expertise for the BIO CEO & Investor Conference
7. Accuray Announces New Treatment Planning Service Offering
8. QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cancer and HealthShares(TM) Neuroscience Indexes
9. Sharps Compliance Corp. Announces Purchase of Medical Waste Disposal Facility and Addition of Autoclave Technology
10. ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use
11. Vapotherm(R) Announces Validation of U.S. Patent

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...EW YORK, Nov. 19 NeoStem... has sent the following letter to its shareholders... 30, 2009, of China Biopharmaceuticals Holdings, I...ny based in the People,s Republic of China. The me...uzhou Eyre Pharmaceutical Co. Ltd., CHBP,s primary...
(Date:11/19/2009)...ONTREAL, Nov. 19 /PRNewswire/ - Aegera Therapeutic...ient in a randomized Phase 2B study of AEG35156, a...opment for multiple oncology indications. ,, Th...2 Study of the X-Linked Inhibitor of Apoptosis (XI...igh-dose Cytarabine and Idarubicin in AML Followin...
(Date:11/19/2009)..., VIENNA, Austria, November 19 /PRNewswire/ -...ogram on one product candidate at an unexpectedly ...AD02 is planned to enter into,Phase II clinical tr...mediately follows the completion of two Phase I tr...y based its fast decision on the first interim,ana...
(Date:11/18/2009)...N, Ill. Imagine a polka-dotted postage stamp that...mply by changing colors. , As reported in the Se...nneth Suslick and his team at the University of Il...eneral detection of toxic industrial chemicals (TI...s by visualizing odors. This sensor array could b...
Breaking Biology Technology:NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3
... Sept. 18 Ingenuity Systems, the,leading provider...cientific,literature and data, is pleased to annou... major public-private biomedical research,partners...biological,markers to support new drug development...he founding members of the Consortium include the ...
...er 18 - Clinical Study Demonstrates Breakthrough... Capacities and Expands Potential Production,Capac... Sanofi pasteur, the vaccines division of sanofi-...ts new investigational H5N1 pandemic influenza,vac...high immune response,at the lowest dose of H5N1 an...
...e University of Pennsylvania have developed nanowi...ears and retrieving that data a thousand times fas...Flash memory and micro-drives, all using less powe...tesh Agarwal, an assistant professor in the Depart...leagues developed a self-assembling nanowire of ge...
Other Biology Technology:Ingenuity Systems Joins Biomarkers Consortium 2Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 2Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 3Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 4Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 5Penn engineers design computer memory in nanoscale form that retrieves data 1,000 times faster 2Penn engineers design computer memory in nanoscale form that retrieves data 1,000 times faster 3
(Date:11/20/2009)...h 2009 - Bacteria possess an ingenious mechanism f...cks of the cell. This is the new finding of a team... a life sciences research institute in Flanders, B...l. The scientists made this discovery by modifying...coli . By means of this model organism, they have ...
(Date:11/20/2009)...ulmonary disease (COPD), a respiratory disease com... the fourth leading cause of death worldwide. 600...rs have yet to find any real treatment or cure, Gr...niversity of Western Ontario in London, Canada, is...ght into the disease. , Parraga is a scienti...
(Date:11/19/2009)...rring brain chemical with an unwieldy name: 4-hydr...ed or used as a date-rape drug. , Now, a team o... routes by which 4-HB is metabolized by the body. ...ichael Gibson, professor and chair of biological s... member of the research team. "It may provide new...
Breaking Biology News(10 mins):Biologists discover bacterial defense mechanism against aggressive oxygen 2Gaining a better picture of lung disease 2Researchers begin to decipher metabolism of sexual assault drug 2Adam Kluger Public Relations Adds Sex Therapist and Psychiatrist Dr Dennis Lin MD to Their All Star Health and Medical Client Roster 60057 1Adam Kluger Public Relations Adds Sex Therapist and Psychiatrist Dr Dennis Lin MD to Their All Star Health and Medical Client Roster 60057 2AMERIGROUP Announces Preliminary Third Quarter Results 60054 1AMERIGROUP Announces Preliminary Third Quarter Results 60054 2AMERIGROUP Announces Preliminary Third Quarter Results 60054 3AMERIGROUP Announces Preliminary Third Quarter Results 60054 4AMERIGROUP Announces Preliminary Third Quarter Results 60054 5Insure com Inc Announces Name Change to Life Quotes Inc and Nasdaq Ticker Symbol Change to QUOT Effective October 28 2009 60051 1Insure com Inc Announces Name Change to Life Quotes Inc and Nasdaq Ticker Symbol Change to QUOT Effective October 28 2009 60051 2
...ntain codeine may be risky for some,breastfeeding ...y of Western Ontario, and the Hospital for Sick Ch...on Koren published research in the journal, Clini...at the codeine used in some pain relief drugs can ...nfants when ingested by some breastfeeding mothers...
...genetic code of a simple saltwater creature could ...nes function in humans and other species. , A stu...aks down the genetic code of Trichoplax , a simpl...in the world, even in the common household aquariu...x , genes that are also found in other animals - o...
...ide algae, Karenia brevis, costs approximately $20...t of Florida alone. Scientists at the Georgia Inst...educe the levels of the red tide,s toxicity to ani...s toxicity to other algae as well. If scientists c...y of red tide, they could reduce the vast amount o...
Other Biology News:Codeine not safe for all breastfeeding moms and their babies 2Genome of saltwater creature could aid understanding of gene grouping 2Biologists find diatom to reduce red tide's toxicity 2Biologists find diatom to reduce red tide's toxicity 3
Gey's Balanced Salt Solution (GBSS) from Sigma-Aldrich
...cations to the original formulas in efforts to pro...y an important role in tissue,culture. A salt solu...tic balance in the medium and to provide the cells...luable today as when it was first developed a cent...
Ellman's Reagent from Cayman Chemical
Synergy HT Multi-Detection Microplate Reader from BioTek Instruments
Biology Products: